Anavex Life Sciences Corp (AVXL)

[tredenwater2]

Absolutely right Bio. Picture this, the Alz trial extensions led to a bio marker. In the new Alz trial, the new PDD trial, and the Rett trial this bio marker will possibly show a continuity for efficacy. Much faster efficacy results too in Rett and PDD (secondary endpoints leading to better QOL) unlike Alz where cognition is harder to prove. When the results in one or both of the new trials confirm the bio marker efficacy coupled with the Alz extended trial results (plus safety) we will have a compelling case for an approval. The bio marker is a major breakthrough IMO.


Tred